We are live on ! Find out more
TCIM

TIAA CREF Investment Management Portfolio holdings

AUM $141B
1-Year Est. Return 14.18%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+14.18%
3 Year Est. Return
+70.07%
5 Year Est. Return
+108.37%
10 Year Est. Return
AUM
$141B
AUM Growth
+$15B
Cap. Flow
-$3.33B
Cap. Flow %
-2.36%
Top 10 Hldgs %
20.05%
Holding
3,067
New
60
Increased
1,132
Reduced
1,578
Closed
64

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$493M
2
MSFT icon
Microsoft
MSFT
+$336M
3
NOC icon
Northrop Grumman
NOC
+$224M
4
NVDA icon
NVIDIA
NVDA
+$208M
5
MAR icon
Marriott International
MAR
+$202M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Financials 14.22%
3 Healthcare 13.74%
4 Consumer Discretionary 11.39%
5 Communication Services 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LBC
2851
DELISTED
Luther Burbank Corporation Common Stock
LBC
$229K ﹤0.01%
22,643
EGAN icon
2852
eGain
EGAN
$183M
$227K ﹤0.01%
21,747
+279
+1% +$2.64K
YMAB
2853
DELISTED
Y-mAbs Therapeutics
YMAB
$227K ﹤0.01%
+8,673
New +$190K
FRBA icon
2854
First Bank
FRBA
$462M
$225K ﹤0.01%
19,508
DOVA
2855
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$223K ﹤0.01%
25,092
SAMG icon
2856
Silvercrest Asset Management
SAMG
$76.1M
$218K ﹤0.01%
15,300
LVO icon
2857
LiveOne
LVO
$61.6M
$217K ﹤0.01%
4,033
+364
+10% +$21.6K
ALV icon
2858
Autoliv
ALV
$9.09B
$215K ﹤0.01%
2,924
-514
-15% -$39.8K
ITI
2859
DELISTED
Iteris, Inc.
ITI
$214K ﹤0.01%
51,361
FRTA
2860
DELISTED
Forterra, Inc
FRTA
$214K ﹤0.01%
50,805
+24,977
+97% +$120K
ODT
2861
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$214K ﹤0.01%
+9,685
New +$169K
CRNX icon
2862
Crinetics Pharmaceuticals
CRNX
$8.85B
$211K ﹤0.01%
9,281
-70
-0.7% -$1.72K
GAIA icon
2863
Gaia
GAIA
$46.8M
$211K ﹤0.01%
23,050
AXNX
2864
DELISTED
Axonics, Inc. Common Stock
AXNX
$211K ﹤0.01%
+8,792
New +$159K
VIA
2865
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$210K ﹤0.01%
4,718
GBL
2866
DELISTED
GAMCO Investors, Inc.
GBL
$210K ﹤0.01%
10,222
BPRN icon
2867
Princeton Bancorp
BPRN
$280M
$208K ﹤0.01%
+6,568
New +$204K
GENC icon
2868
Gencor Industries
GENC
$211M
$207K ﹤0.01%
16,735
NAGE
2869
Niagen Bioscience
NAGE
$264M
$206K ﹤0.01%
49,224
SLDB icon
2870
Solid Biosciences
SLDB
$836M
$204K ﹤0.01%
1,476
-26
-2% -$6.51K
SYBX
2871
DELISTED
Synlogic
SYBX
$201K ﹤0.01%
1,764
-437
-20% -$53.6K
BITA
2872
DELISTED
Bitauto Holdings Limited
BITA
$201K ﹤0.01%
12,600
-3,600
-22% -$66.2K
GYRE icon
2873
Gyre Therapeutics
GYRE
$648M
$199K ﹤0.01%
3,278
+1,061
+48% +$68.2K
SIBN icon
2874
SI-BONE Inc
SIBN
$798M
$198K ﹤0.01%
10,525
PTE
2875
DELISTED
PolarityTE, Inc. Common Stock
PTE
$198K ﹤0.01%
739

Similar funds

TIAA CREF Investment Management's Q1 2019 Portfolio in Review

As of Q1 2019, TIAA CREF Investment Management held 3,067 positions worth $141B, up 12% from $126B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4%. TIAA CREF Investment Management opened 60 new positions and exited 64, leaving the 3,067-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • TIAA CREF Investment Management's largest Q1 2019 buy was Takeda Pharmaceutical: 6,555,742 shares worth $134M.
  • TIAA CREF Investment Management added most to Meta Platforms (Facebook) in Q1 2019, an estimated $253M increase.
  • TIAA CREF Investment Management's biggest Q1 2019 reduction was JPMorgan Chase, cutting an estimated $493M.
  • TIAA CREF Investment Management fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $165M.
  • TIAA CREF Investment Management's ten largest holdings make up 20% of its $141B portfolio in Q1 2019.
  • TIAA CREF Investment Management opened 60 new positions and closed 64 in Q1 2019.
  • TIAA CREF Investment Management's portfolio value rose 12% quarter-over-quarter to $141B.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.